Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Champlin

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 15, 2018
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapyHaige Ye, Aakash Desai, Shengjian Huang, et al.
Cancer|February 24, 2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaElias Jabbour, Sergio Giralt, Hagop Kantarjian, et al.
The Internet Journal of Hematology|October 31, 2014
The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant OutcomesYvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, et al.
Cancer|November 17, 2011
Durable remission with salvage second autotransplants in patients with multiple myelomaNina Shah, Fraz Ahmed, Qaiser Bashir, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host diseaseDaniel R Couriel, Rima Saliba, Marcos de Lima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2004
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphomaKoen Van Besien, Rakesh Mehra, Navin Wadehra, et al.
European Journal of Haematology|November 19, 2016
Predictors of inferior clinical outcome in patients with standard-risk multiple myelomaTalha Badar, Samer Srour, Qaiser Bashir, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2017
Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin LymphomaSai Ravi Pingali, Rima M Saliba, Paolo Anderlini, et al.
Acta Haematologica|May 22, 2019
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell TransplantationZhihong Zeng, Wenbin Liu, Christopher B Benton, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 15, 2018
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapyHaige Ye, Aakash Desai, Shengjian Huang, et al.
Cancer|February 24, 2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaElias Jabbour, Sergio Giralt, Hagop Kantarjian, et al.
The Internet Journal of Hematology|October 31, 2014
The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant OutcomesYvonne A Efebera, Rupinderjit S Thandi, Rima M Saliba, et al.
Cancer|November 17, 2011
Durable remission with salvage second autotransplants in patients with multiple myelomaNina Shah, Fraz Ahmed, Qaiser Bashir, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host diseaseDaniel R Couriel, Rima Saliba, Marcos de Lima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2004
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphomaKoen Van Besien, Rakesh Mehra, Navin Wadehra, et al.
European Journal of Haematology|November 19, 2016
Predictors of inferior clinical outcome in patients with standard-risk multiple myelomaTalha Badar, Samer Srour, Qaiser Bashir, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2017
Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin LymphomaSai Ravi Pingali, Rima M Saliba, Paolo Anderlini, et al.
Acta Haematologica|May 22, 2019
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell TransplantationZhihong Zeng, Wenbin Liu, Christopher B Benton, et al.
Pageof 22